Skip to content

BD BBL™ VDRL Antigen 240765Recalls & reported problems

Becton, Dickinson And Company · BD BBL™ VDRL Antigen · Class 2

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00382902407652), received between Mar 1, 2022 and Jul 25, 2024 — classified as 3 malfunctions.

The most frequently reported specific device problem is “Incorrect, Inadequate or Imprecise Result or Readings” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 1 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Incorrect, Inadequate or Imprecise Result or Readings2
  • False Negative Result1

Patient problems

  • No Clinical Signs, Symptoms or Conditions3

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJul 25, 2024Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

    IT WAS REPORTED WHILE USING THE BD BBL¿ VDRL ANTIGEN THE SALINE SOLUTION PH IS INCONSISTENT BETWEEN SEVERAL TESTING METHODS, PH TEST STRIPS, PH METER/PROBE, AND MULTISTICK. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 19824447 ↗
  • MalfunctionNov 14, 2022False Negative Result; False Negative Result

    IT WAS REPORTED THAT BD BBL¿ VDRL ANTIGEN FALSE NEGATIVE OCCURRED. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: CUSTOMER REPORTED 1). CAP SURVEY "GA"; MAY 16, 2022; SAMPLE #G-02 WAS "REACTIVE" WHILE WAS SUPPOSED TO BE A NEG. ATTACHED SURVEY SAYS G-02 WAS NON REACTIVE AND THE INTENDED REPORT IS REACTIVE. HAZARD, INJURY OR ERRONEOUS RESULTS DETAILS WHICH ASSAYS OR TESTS ARE EXHIBITING ISSUES? 240765. ARE THE VALUES OF THE ASSAYS AVAILABLE? YES. ANALYZER NAME & MODEL #N/A. HOW MANY UNITS (TUBES) AFFECTED? 1. WHAT IS THE FREQUENCY OR OCCURRENCE RATE (1 DAY, % OF TUBES AFFECTED, PATIENTS INVOLVED, HOW MANY TESTS PER DAY ETC.) PT. WHAT WAS METHOD OF DRAW?; STRAIGHT NEEDLE; WINGSET; SYRINGE; LINE; UNSURE/OTHER (PLEASE LIST) PT. IS TUBE FILLED TO STATED VOLUME? UNKNOWN. WHAT WAS ORDER OF DRAW? N/A. HOW MANY TIMES WAS THE TUBE INVERTED? UNKNOWN. HOW WERE TUBES TRANSPORTED? (PNEUMATIC SYSTEM, CARRIER, ETC.) N/A. HOW LONG AFTER COLLECTION WERE TUBES PROCESSED? N/A.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 15788447 ↗
  • MalfunctionMar 1, 2022Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

    IT WAS REPORTED WHEN USING THE BD BBL¿ VDRL ANTIGEN THERE WAS A PERFORMANCE ISSUE. THE PH WAS OUT OF RANGE. THERE WAS NO REPORT OF ADVERSE PATIENT IMPACT. THIS EVENT OCCURRED 5 TIMES. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER. THE CUSTOMER STATED: "THE PH OF VDRL BUFFERED SALINE IS OUT OF RANGE. THE BUFFERED SALINE SEEMS TO ONLY BE REACHING A PH OF ~5.3-5.7. CUSTOMER OPENED SEVERAL KITS, USED CURRENT AS WELL AS A BRAND NEW PH METER TO TEST THE PH AND NONE OF THEM REACHED THE REQUIRED 6.0 +/- 1 READING." CUSTOMER HAS CONFIRMED NOT DEVIATING FROM THE PACKAGE INSERT. CUSTOMER CHECKED THE PH WITH PH PAPER IN ADDITION TO OUR USUAL METHOD OF THE EXTECH. THE PH PAPER RESULTS MATCHED THE EXTECH. THE PROBE IS CALIBRATED BEFORE EACH USE."

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 13641133 ↗

Other ANTIGENS, NONTREPONEMAL, ALL devices

All ANTIGENS, NONTREPONEMAL, ALL devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page